Back to Search
Start Over
Topical halobetasol propionate in the treatment of plaque psoriasis: a review.
- Source :
-
American journal of clinical dermatology [Am J Clin Dermatol] 2005; Vol. 6 (5), pp. 311-6. - Publication Year :
- 2005
-
Abstract
- Halobetasol propionate (HP) 0.5% ointment and cream are class I topical corticosteroids. We review the efficacy and tolerability of HP for treatment of plaque psoriasis in the English language literature. The efficacy of HP ointment and cream is consistently superior to other super-potent topical corticosteroids. Local adverse events associated with topical HP are similar to those experienced with other super-potent corticosteroids. Combination therapy with calcipotriene (calcipotriol) and tazarotene appears to be superior to monotherapy with topical HP.
- Subjects :
- Administration, Topical
Clobetasol adverse effects
Clobetasol therapeutic use
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Male
Maximum Tolerated Dose
Risk Assessment
Severity of Illness Index
Treatment Outcome
Clobetasol analogs & derivatives
Psoriasis drug therapy
Psoriasis pathology
Subjects
Details
- Language :
- English
- ISSN :
- 1175-0561
- Volume :
- 6
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- American journal of clinical dermatology
- Publication Type :
- Academic Journal
- Accession number :
- 16252930
- Full Text :
- https://doi.org/10.2165/00128071-200506050-00004